Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1 Article

Chen, Wei, Tuladhar, Anupama, Rolle, Shantelle et al. (2017). Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1 . TOXICOLOGY AND APPLIED PHARMACOLOGY, 329 58-66. 10.1016/j.taap.2017.05.027

Open Access

cited authors

  • Chen, Wei; Tuladhar, Anupama; Rolle, Shantelle; Lai, Yanhao; del Rey, Freddy Rodriguez; Zavala, Cristian E; Liu, Yuan; Rein, Kathleen S

sustainable development goals

authors

publication date

  • August 15, 2017

webpage

published in

keywords

  • ANTIPROLIFERATIVE ACTIVITY
  • ANTITUMOR QUINOLS
  • Brevetoxin
  • CELLULAR-METABOLISM
  • EXPOSURE
  • FLORIDA
  • IMMUNE-SYSTEM
  • IN-VITRO
  • Karenia brevis
  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • SELENIUM
  • Science & Technology
  • TIDE
  • TRICHECHUS-MANATUS-LATIROSTRIS
  • Thioredoxin
  • Thioredoxin reductase
  • Toxicology

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 58

end page

  • 66

volume

  • 329